The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

A new study shows that coffee is among the most commonly used "natural health products" used by people with Parkinson's ...

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from McGill University could reactivate housekeeping functions in brain ...

A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...